Talk about your career arc and how that has led to a passion for stewardship leadership.

Great.

Happy to do that.

So I'm a lifelong Texan.

I live and work in the Texas panhandle, Amarillo, Texas.

And I've been in finance and accounting since I graduated And so I've been doing the stinking accountant thing for a while.

I'll explain where that name came from in a little bit.

Maybe they do and maybe they don't when it comes to the way you define it, Eric, and you've lived it, so talk about that.

Can you summarize for us what you pointed out in the paper and what kind of suits you're expecting to come?

Sure.

So the paper from the Washington Legal Foundation talked about both what's going on in the social media litigation in general, where there are multiple fronts and multiple types of cases and multiple trials at any given time, and what that might mean more broadly.

And so I think the big premise is this.

Bad cases make bad law, and really sympathetic plaintiffs make judges expand liability.

And I think that's what we're seeing, and I think what we're going to expect, yeah, there'll be a lot of appeals and judges will reverse things.

There are going to be contradictory rulings.

So it'd be interesting to to unpack what the settlers perhaps I'm not asking you to speak to what was in their heads, but just from a legal strategy standpoint, why it might make sense in their minds to settle and why it makes sense into other platforms minds to go all the way to verdict.

Yeah.

There's a really helpful resource, Stephen Covey.

Okay, there's the Stephen R.

Covey, The Seven Habits.

He's passed.

The Seven Habits, very influential.

His son, Stephen M. R.

The psyche, the mindset

How do you see that?

Yeah, I'm very well, I do think the patient and physician discussion is always key and paramount.

So I don't want to overstep that.

But I will say that I am rare to ever recommend a fine needle aspiration for a nodule, certainly under one centimeter.

And in general, that that I think cutoff is becoming even more liberal, arguably one point five centimeters.

And so I think that kind of acknowledgement to the patient that you would not recommend such and why is that, I think, can go a long way.

I do think there's a whole other subgroup when nodules get a bit larger than that, where it's very feasible to ask the question, do you really need the biopsy or not? And I've seen patients go both ways on that.

Do you have a way of reassuring them just generally?